title: Reverse multidrug resistance in laryngeal cancer cells by knockdown MDR1 gene expression.
abstract: BACKGROUND
  Resistance to chemotherapeutic agents is one of the major obstacles in the treatment of laryngeal cancer. Upregulated expression of P-glycoprotein (Pgp), the MDR1 gene product, confers multidrug resistance (MDR) to laryngeal cancer cells. In this study, we reversed the resistance to chemotherapeutic agents in human laryngeal cancer cells (LSC-1/TAX) by using the lentivirus-based small hairpin interference ribonucleic acid (shRNA) technique.
  
  
  METHODS
  LSC-1/TAX cells were transfected with lentivirus vector that contains the shRNA construct targeting MDR1 messenger ribonucleic acid (mRNA). The knockdown of MDR1 gene expression was assessed by reverse transcription polymerase chain reaction (RT-PCR), and the protein level of Pgp was determined by Western blot and immunocytochemistry. Sensitization of the laryngeal cancer cells to various antineoplasm agents will be quantified by methylthiazolyl tetrazolium (MTT) assays. Apoptosis was analyzed by flow cytometry.
  
  
  RESULTS
  It was shown that MDR1 shRNA transfection reduced the MDR1 gene expression in LSC-1/TAX cells by RT-PCR experiment. Western blot and immunocytochemistry showed that Pgp expression was significantly and specifically inhibited. MTT assay revealed a reverse of MDR1 gene-dependent MDR in the laryngeal cancer cells using shRNA lentivirus vectors. Increased apoptosis has been observed in the MDR1 knockdown LSC-1/TAX cells when exposed to paclitaxel (TAX) treatment.
  
  
  CONCLUSIONS
  MDR1 shRNA lentivirus vectors can significantly inhibit MDR1 expression at both mRNA and protein levels. Inhibition of MDR1 gene expression conferred an increased sensitivity to drug resistance in laryngeal cancer cells to conventional chemotherapeutic agents.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
authors.forename: Huang
authors.initials: H
authors.lastname: Zhigang
authors.forename: Zhong
authors.initials: Z
authors.lastname: Qi
authors.forename: Fang
authors.initials: F
authors.lastname: Jugao
authors.forename: Chen
authors.initials: C
authors.lastname: Xiaohong
authors.forename: Zhang
authors.initials: Z
authors.lastname: Wei
authors.forename: Wang
authors.initials: W
authors.lastname: Hong
authors.forename: Hei
authors.initials: H
authors.lastname: Hu
authors.forename: Meng
authors.initials: M
authors.lastname: Na
authors.forename: Yang
authors.initials: Y
authors.lastname: Zheng
authors.forename: Han
authors.initials: H
authors.lastname: Demin
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics*; D045744:Cell Line, Tumor; D018432:Drug Resistance, Multiple / Q000235:genetics*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D015870:Gene Expression; D055785:Gene Knockdown Techniques; D006801:Humans; D007822:Laryngeal Neoplasms / Q000235:genetics*
chemical_list: C513055:ABCB1 protein, human; D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1